SinoMab Bioscience
Tai Po
About SinoMab Bioscience
SinoMab Bioscience is a biopharmaceutical company. They develop therapeutic antibodies for the treatment of life-threatening diseases. They treat rheumatoid arthritis, immunological diseases, and systemic lupus erythematosus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Funding stage: IPO
- Last round: Series Unknown (Feb 2019)
- Ticker: hkg:3681
- Website: sinomab.com
- Phone: 852 3426 9833
Industries & Categories
Biotechnology, Health Care, Manufacturing, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/sinomab-bioscience-1112243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.